SAMAD SAM 4

What Happened

• Samad Sam, Executive Vice President & CFO of Quest Diagnostics (DGX), was issued 13,947 shares as a performance stock award on March 4, 2026 (grant code A) valued at $204.86/share, totaling about $2,857,182.
• On the same date he surrendered 7,720 shares back to the company (disposition code F) at $204.86/share to cover tax withholding obligations, representing about $1,581,519.

Key Details

• Transaction date: 2026-03-04; Form filed: 2026-03-06 (filed timely).
• Award: 13,947 shares issued at $204.86/share (total ≈ $2,857,182).
• Tax withholding: 7,720 shares surrendered at $204.86/share (total ≈ $1,581,519).
• Footnotes: F1 — shares issued in settlement of a performance stock award under Rule 16b‑3(d). F2 — shares disposed solely to cover tax withholding from the award.
• Shares owned after the transaction: not stated in the provided filing details.

Context

• This was a settlement of a performance-based equity award (not an open-market buy or sale). The partial surrender of shares to the issuer to satisfy tax withholding is a routine administrative step and does not necessarily indicate a change in the insider’s view of the company.